Three cases of viral liver injury with a decrease in serum CA19-9 level after antiviral therapy

DOI Web Site Web Site 25 References
  • Fukuda Wataru
    Department of Gastroenterology, Osaka General Hospital of West Japan Railway Company Present address: Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science
  • Mitsumoto Yasuhide
    Department of Gastroenterology, Osaka General Hospital of West Japan Railway Company Present address: Department of Gastroenterology, Social Insurance Kyoto Hospital
  • Mori Takahiro
    Department of Gastroenterology, Osaka General Hospital of West Japan Railway Company
  • Shimizu Seiji
    Department of Gastroenterology, Osaka General Hospital of West Japan Railway Company
  • Okanoue Takeshi
    Center of Gastroenterology and Hepatology, Saiseikai Suita Hospital

Bibliographic Information

Other Title
  • 抗ウイルス療法により高CA19-9血症の改善を認めたウイルス性肝疾患の3症例
  • 症例報告 抗ウイルス療法により高CA19-9血症の改善を認めたウイルス性肝疾患の3症例
  • ショウレイ ホウコク コウウイルス リョウホウ ニ ヨリ コウCA19-9 ケツショウ ノ カイゼン オ ミトメタ ウイルスセイ ギモ シッカン ノ 3 ショウレイ

Search this article

Abstract

It was reported that elevated serum CA19-9 levels in chronic liver injuries decreased in proportion to the improvement of the liver injuries after treatment. Case 1 was 48-year-old woman with chronic hepatitis B. Case 2 was 69-year-old man with hepatitis C virus (HCV)-related cirrhosis. Case 3 was 75-year-old man with chronic hepatitis C. In the present 3 cases, serum CA19-9 levels significantly decreased after successful antiviral treatment for viral hepatitis. These results indicate that liver injury might induce significant elevation of serum CA19-9 without malignant diseases.<br>

Journal

  • Kanzo

    Kanzo 53 (2), 109-116, 2012

    The Japan Society of Hepatology

References(25)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top